Literature DB >> 9300637

Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells.

C Zona1, M T Ciotti, M Avoli.   

Abstract

Whole-cell, voltage-clamp recordings were made from rat cerebellar granule cells in culture under experimental conditions designed to study voltage-gated Na+ currents that were elicited by depolarizing commands from a holding potential of -60 mV up to +20 mV. These tetrodotoxin-sensitive inward currents were reduced in a dose-related manner by bath application of the structurally novel, anticonvulsant drug topiramate (10-1000 microM; n = 16). Dose-response analysis of this effect revealed an IC50 of 48.9 microM. Topiramate also made the steady-state inactivation curve of this current shift toward more negative values (midpoint of the inactivation curve -46.9 mV under control conditions and -56.5 mV during topiramate application; n = 5). We propose that these effects may contribute to control the sustained depolarizations with repetitive firing of action potentials that occur within neuronal networks during seizure activity. Therefore they may represent a mechanism of action for this novel anticonvulsant drug.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300637     DOI: 10.1016/s0304-3940(97)00543-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  40 in total

1.  Antiepileptic drugs and cortical excitability: a study with repetitive transcranial stimulation.

Authors:  M Inghilleri; A Conte; V Frasca; A Curra'; F Gilio; M Manfredi; A Berardelli
Journal:  Exp Brain Res       Date:  2003-10-25       Impact factor: 1.972

2.  Pregabalin- and topiramate-mediated regulation of cognitive and motor impulsivity in DBA/2 mice.

Authors:  Francisco Navarrete; José M Pérez-Ortiz; Jorge Manzanares
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 3.  Hypothalamic regulatory pathways and potential obesity treatment targets.

Authors:  Erin E Jobst; Pablo J Enriori; Puspha Sinnayah; Michael A Cowley
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

4.  Phosphorylation of sodium channels mediated by protein kinase-C modulates inhibition by topiramate of tetrodotoxin-sensitive transient sodium current.

Authors:  G Curia; P Aracri; E Colombo; P Scalmani; M Mantegazza; G Avanzini; S Franceschetti
Journal:  Br J Pharmacol       Date:  2007-02-05       Impact factor: 8.739

Review 5.  Synergistic neuroprotective therapies with hypothermia.

Authors:  Maria Roberta Cilio; Donna M Ferriero
Journal:  Semin Fetal Neonatal Med       Date:  2010-03-07       Impact factor: 3.926

6.  Topiramate and cortical excitability in humans: a study with repetitive transcranial magnetic stimulation.

Authors:  M Inghilleri; F Gilio; A Conte; V Frasca; C Marini Bettolo; E Iacovelli; B Gregori; M Prencipe; A Berardelli
Journal:  Exp Brain Res       Date:  2006-08-05       Impact factor: 1.972

7.  The effects of topiramate on caspase-3 expression in hippocampus of basolateral amygdala (BLA) electrical kindled epilepsy rat.

Authors:  Xuqin Chen; Guanshui Bao; Ying Hua; Yan Li; Zhedong Wang; Xueguang Zhang
Journal:  J Mol Neurosci       Date:  2009-01-16       Impact factor: 3.444

8.  Effect of repeated treatment with topiramate on voluntary alcohol intake and beta-endorphin plasma level in Warsaw alcohol high-preferring rats.

Authors:  Jadwiga Zalewska-Kaszubska; Bartosz Bajer; Dorota Gorska; Dariusz Andrzejczak; Wanda Dyr; Przemysław Bieńkowski
Journal:  Psychopharmacology (Berl)       Date:  2012-07-31       Impact factor: 4.530

9.  Topiramate modulates pH of hippocampal CA3 neurons by combined effects on carbonic anhydrase and Cl-/HCO3- exchange.

Authors:  Tobias Leniger; Jan Thöne; Martin Wiemann
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

10.  Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy.

Authors:  Stéphane Auvin
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.